Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Annette S Kim, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Craig JW, Hasserjian RP, Kim AS, Aster JC, Pinkus GS, Hornick JL, Steensma DP, Coleman Lindsley R, DeAngelo DJ, Morgan EA. Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis. Mod Pathol. 2020 Jan 02. PMID: 31896808.
    Citations:    
  2. Shanmugam V, Parnes A, Kalyanaraman R, Morgan EA, Kim AS. Clinical utility of targeted next-generation sequencing-based screening of peripheral blood in the evaluation of cytopenias. Blood. 2019 Dec 12; 134(24):2222-2225. PMID: 31697812.
    Citations:    
  3. Khatri SS, Kim AS. Li-Fraumeni syndrome presenting as precursor B lymphoblastic leukemia mimicking intravascular large B-cell lymphoma. Blood. 2019 09 19; 134(12):993. PMID: 31537539.
    Citations:    
  4. Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS. Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Arch Pathol Lab Med. 2019 Oct; 143(10):1203-1211. PMID: 30969158.
    Citations:    
  5. Surrey LF, Oakley FD, Merker JD, Long TA, Vasalos P, Moncur JT, Kim AS. Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on BRAF, EGFR, and KRAS Proficiency Testing Samples. Arch Pathol Lab Med. 2019 Aug; 143(8):980-984. PMID: 30865489.
    Citations:    
  6. Merker JD, Devereaux K, Iafrate AJ, Kamel-Reid S, Kim AS, Moncur JT, Montgomery SB, Nagarajan R, Portier BP, Routbort MJ, Smail C, Surrey LF, Vasalos P, Lazar AJ, Lindeman NI. Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays. Arch Pathol Lab Med. 2019 04; 143(4):463-471. PMID: 30376374.
    Citations:    Fields:    
  7. McClure RF, Ewalt MD, Crow J, Temple-Smolkin RL, Pullambhatla M, Sargent R, Kim AS. Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms: A Report of the Association for Molecular Pathology. J Mol Diagn. 2018 11; 20(6):717-737. PMID: 30138727.
    Citations:    
  8. Shanmugam V, Morgan EA, DeAngelo DJ, Kim AS. Many faces of the same myeloid neoplasm: a case of leukaemia cutis with mixed histiocytic and Langerhans cell differentiation. J Clin Pathol. 2019 01; 72(1):93-96. PMID: 30093508.
    Citations:    Fields:    
  9. Kim AS, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Moncur JT. Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing. JAMA Oncol. 2018 06 01; 4(6):838-841. PMID: 29242895.
    Citations:    Fields:    
  10. Wheeler FC, Kim AS, Mosse CA, Shaver AC, Yenamandra A, Seegmiller AC. Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up. Am J Clin Pathol. 2018 Mar 29; 149(5):418-424. PMID: 29538617.
    Citations:    
  11. Cortazar JM, Kim AS. Incidental Langerhans cell histiocytosis of the colon with BRAF p.V600E mutation. Blood. 2017 10 19; 130(16):1870. PMID: 29051154.
    Citations:    Fields:    Translation:Humans
  12. Wang-Rodriguez J, Yunes A, Phan R, Ma N, Baddoura F, Mosse C, Kim AS, Lu CM, Dong DZM, Schichman S, Icardi M, Ehsan A. The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA. Fed Pract. 2017 Aug; 34(Suppl 5):S50-S61. PMID: 30766310.
    Citations:    
  13. Seegmiller AC, Kim AS, Mosse CA, Shaver AC, Thompson MA, Li S, Head DR, Zutter MM. Data-Driven Iterative Refinement of Bone Marrow Testing Protocols Leads to Progressive Improvement in Cytogenetic and Molecular Test Utilization. Am J Clin Pathol. 2016 Nov 01; 146(5):585-593. PMID: 27769956.
    Citations:    
  14. Rosado FG, Rinker EB, Plummer WD, Dupont WD, Spradlin NM, Reichard KK, Kim AS. The diagnosis of adult-onset haemophagocytic lymphohistiocytosis: lessons learned from a review of 29 cases of bone marrow haemophagocytosis in two large academic institutions. J Clin Pathol. 2016 Sep; 69(9):805-9. PMID: 26896491.
    Citations:    Fields:    Translation:Humans
  15. Rinker EB, Dueber JC, Qualtieri J, Tedesco J, Erdogan B, Bosompem A, Kim AS. Differential expression of ribosomal proteins in myelodysplastic syndromes. J Clin Pathol. 2016 Feb; 69(2):176-80. PMID: 26408650.
    Citations:    Fields:    Translation:HumansCells
  16. Smith MC, Kressin MK, Crawford E, Wang XJ, Kim AS. B Lymphoblastic Leukemia With a Novel t(11;15) (q23;q15) and Unique Burkittoid Morphologic and Immunophenotypic Findings in a 9-Year-Old Boy. Lab Med. 2015; 46(4):320-6. PMID: 26489677.
    Citations:    
  17. Douds JJ, Long DJ, Kim AS, Li S. Diagnostic and prognostic significance of CD200 expression and its stability in plasma cell myeloma. J Clin Pathol. 2014 Sep; 67(9):792-6. PMID: 24958785.
    Citations: 2     Fields:    Translation:HumansCells
  18. Shaver AC, Ma L, Vnencak-Jones C, Schwarting RS, Fasig KJ, Kim AS. Transformation of small B-cell lymphoma into large cell CD30?, CD4?, Epstein-Barr virus-negative lymphoma. Arch Pathol Lab Med. 2014 Aug; 138(8):1101-5. PMID: 25076300.
    Citations:    
  19. Ondrejka SL, Jegalian AG, Kim AS, Chabot-Richards DS, Giltnane J, Czuchlewski DR, Shetty S, Sekeres MA, Yenamandra A, Head D, Jagasia M, Hsi ED. PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin. Haematologica. 2014 Sep; 99(9):e148-51. PMID: 24951465.
    Citations:    
  20. Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Kressin MK, Jagasia MH, Strickland SA, Reddy NM, Marx ER, Sinkfield KJ, Pollard HN, Plummer WD, Dupont WD, Shultz EK, Dittus RS, Stead WW, Santoro SA, Zutter MM. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am J Clin Pathol. 2013 Nov; 140(5):643-50. PMID: 24124142.
    Citations:    
  21. Seegmiller AC, Wasserman A, Kim AS, Kressin MK, Marx ER, Zutter MM, Mosse CA. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms. Leuk Lymphoma. 2014 Mar; 55(3):601-5. PMID: 23876099.
    Citations:    
  22. Erdogan B, Bosompem A, Peng D, Han L, Smith E, Kennedy ME, Alford CE, Wu H, Zhao Z, Mosse CA, El-Rifai W, Kim AS. Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes. Leuk Lymphoma. 2013 Dec; 54(12):2720-7. PMID: 23547841.
    Citations:    
  23. Hart AJ, Jagasia MH, Kim AS, Mosse CA, Savani BN, Kassim A. Minimal residual disease in myeloma: are we there yet? Biol Blood Marrow Transplant. 2012 Dec; 18(12):1790-9. PMID: 22626785.
    Citations:    
  24. Kim AS, Goldstein SC, Luger S, Van Deerlin VM, Bagg A. Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib? Am J Clin Pathol. 2008 Apr; 129(4):639-48. PMID: 18343792.
    Citations:    
  25. Peterson JR, Bickford LC, Morgan D, Kim AS, Ouerfelli O, Kirschner MW, Rosen MK. Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation. Nat Struct Mol Biol. 2004 Aug; 11(8):747-55. PMID: 15235593.
    Citations: 74     Fields:    Translation:AnimalsCells
  26. Kim AS. Clinical impact of gene expression profiling on oncology diagnosis, prognosis, and treatment. Comb Chem High Throughput Screen. 2004 May; 7(3):183-206. PMID: 15134525.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (158)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.